Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308
Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308

Mounjaro vs Rybelsus

Compare Mounjaro and Rybelsus on active ingredient, dosing schedule, FDA-approved use and pharmacy acquisition cost.

By Sam Reed · Founder and data leadVerified Aug 12, 2026

Mounjaro

Eli Lilly

Active ingredient
Tirzepatide
Form
INJECTION, SOLUTION
FDA-approved for
Type 2 diabetes
$1,077
lowest package, pharmacy acquisition cost

Rybelsus

Novo Nordisk

Active ingredient
Semaglutide
Form
TABLET
FDA-approved for
Type 2 diabetes
$995
lowest package, pharmacy acquisition cost

The short answer

Mounjaro contains Tirzepatide and Rybelsus contains Semaglutide. These are different molecules, so their dosing and clinical evidence differ.

Side by side

Costs are what a pharmacy pays to acquire each product, from CMS NADAC. Not a retail price, and not what you would pay.

Mounjaro
Rybelsus
Lowest package cost
$1,077
$995
Active ingredient
Tirzepatide
Semaglutide
Manufacturer
Eli Lilly
Novo Nordisk
Form
INJECTION, SOLUTION
TABLET
FDA-approved for
Type 2 diabetes
Type 2 diabetes
= better value on that rowScroll sideways on small screens — the first column stays pinned
Keep comparing
Data sources · cited with retrieval dates
  • CMS NADACNational Average Drug Acquisition Cost, weekly fileretrieved Aug 12, 2026
  • CMS Medicare Part DPrescriber public use file, by geography and drugretrieved Aug 12, 2026
  • CMS State Drug UtilizationQuarterly Medicaid prescription and reimbursement dataretrieved Aug 12, 2026

NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.